Is my portfolio
One Report to Answer all your Questions!
Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1166.45
-9.10 (-0.77%) Dr. Reddy's receives EIR from USFDA for closure of inspection
Date: 21-02-2022Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) indicating closure of the inspection at its formulations manufacturing facilities (FTO 7 & FTO 9) at Duvvada in Visakhapatnam.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.